Bladder cancer: Pioglitazone-when is a prescription drug safe?

Yoon Kong Loke; Katharina Mattishent

首页> 外文期刊>Nature reviews. Urology >Bladder cancer: Pioglitazone-when is a prescription drug safe?

【24h】

Bladder cancer: Pioglitazone-when is a prescription drug safe?

机译：膀胱癌：吡格列酮-什么时候处方药安全？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

According to our ONI risk map, the proximal part of the obturator nerve is at higher risk for injury during PLND. Careful dissection and a good knowledge of pelvic anatomy are essential for preventing ONI. Successful ONI management can be performed simultaneously in experienced hands.

机译：根据我们的ONI风险图，在PLND期间，闭孔神经的近端受伤风险更高。仔细解剖和对盆腔解剖学有充分的了解对于预防ONI至关重要。成功的ONI管理可以在经验丰富的人员中同时执行。

著录项

来源
《Nature reviews. Urology》 |2015年第12期|共2页
作者
Yoon Kong Loke; Katharina Mattishent;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Bladder cancer: Pioglitazone-when is a prescription drug safe? [J] . Yoon Kong Loke, Katharina Mattishent Nature reviews. Urology . 2015,第12期

机译：膀胱癌：吡格列酮-什么时候处方药安全？
2. Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue [J] . Faillie Jean-Luc, Hillaire-Buys Dominique Pharmacoepidemiology and drug safety . 2016,第2期

机译：制药业如何扭曲药物安全性证据的例子：吡格列酮和膀胱癌问题
3. Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue [J] . Faillie Jean-Luc, Hillaire-Buys Dominique Pharmacoepidemiology and drug safety . 2016,第2期

机译：制药行业如何扭曲药物安全证据的例子：吡格列酮和膀胱癌问题的情况
4. Safety of three sequential whole bladder photodynamic therapy (WBPDT) treatments in the management of resistant bladder cancer [C] . Maria C. Mejia, Unyime O. Nseyo Photonic therapeutics and diagnostics V . 2009

机译：三种顺序的全膀胱光动力疗法（WBPDT）治疗在耐药性膀胱癌管理中的安全性
5. The Food and Drug Administration's new drug approvals and market withdrawals for safety under the Prescription Drug User Fee Act and the Food and Drug Modernization Act. [D] . Dziurzynski, Bogdan. 2005

机译：食品和药物管理局根据《处方药使用者费用法》和《食品和药物现代化法》为安全起见批准了新药，并撤出了市场。
6. Reply to the Commentary on Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data 2012–2016 [O] . Jong Won Kim, Kang Su Cho 2021

机译：基于国家健康保险索赔数据2012-2016的男性过度活跃膀胱季节性速度季节变化评论
7. Do faster food and drug administration drug reviews adversely affect patient safety? An analysis of the 1992 prescription drug user fee act [O] . Grabowski, H, Wang, YR 2008

机译：更快的食品和药物管理药物审查会对患者安全产生不利影响吗？对1992年处方药使用者费用法的分析
8. Prescription Drug User Fee Act (PDUFA) IV Drug Safety Five-Year Plan 2008 - 2012 [R] . 2008

机译：处方药用户感觉法（pDUFa）IV药物安全五年计划2008-2012

Bladder cancer: Pioglitazone-when is a prescription drug safe?

摘要

著录项

相似文献

相关主题

期刊订阅